Literature DB >> 19494297

B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Iris Castro1, Jacqueline A Wright, Bazarragchaa Damdinsuren, Kristen L Hoek, Gianluca Carlesso, Nicholas P Shinners, Rachel M Gerstein, Robert T Woodland, Ranjan Sen, Wasif N Khan.   

Abstract

Signaling from the BCR and B cell activating factor receptor (BAFF-R or BR3) differentially regulates apoptosis within early transitional (T1) and late transitional (T2; CD21(int)-T2) B cells during selection processes to generate mature B lymphocytes. However, molecular mechanisms underlying the differential sensitivity of transitional B cells to apoptosis remain unclear. In this study, we demonstrate that BCR signaling induced more long-term c-Rel activation in T2 and mature than in T1 B cells leading to increased expression of anti-apoptotic genes as well as prosurvival BAFF-R and its downstream substrate p100 (NF-kappaB2). Sustained c-Rel activation required de novo c-Rel gene transcription and translation via Btk-dependent mechanisms. Like T1 cells, mature B cells from Btk- and c-Rel-deficient mice also failed to activate these genes. These findings suggest that the gain of survival potential within transitional B cells is dependent on the ability to produce a long-term c-Rel response, which plays a critical role in T2 B cell survival and differentiation in vivo by inducing anti-apoptotic genes, BAFF-R and NF-kappaB2, an essential component for BAFF-R survival signaling. Thus, acquisition of resistance to apoptosis during transitional B cell maturation is achieved by integration of BCR and BAFF-R signals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494297      PMCID: PMC2770265          DOI: 10.4049/jimmunol.0803281

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  A B-cell receptor-specific selection step governs immature to mature B cell differentiation.

Authors:  M H Levine; A M Haberman; D B Sant'Angelo; L G Hannum; M P Cancro; C A Janeway; M J Shlomchik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 2.  Rel/NF-kappaB transcription factors: key mediators of B-cell activation.

Authors:  R Gugasyan; R Grumont; M Grossmann; Y Nakamura; T Pohl; D Nesic; S Gerondakis
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

3.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

4.  The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.

Authors:  M Grossmann; L A O'Reilly; R Gugasyan; A Strasser; J M Adams; S Gerondakis
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

5.  Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation.

Authors:  D Allman; R C Lindsley; W DeMuth; K Rudd; S A Shinton; R R Hardy
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

6.  TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS.

Authors:  J A Gross; S R Dillon; S Mudri; J Johnston; A Littau; R Roque; M Rixon; O Schou; K P Foley; H Haugen; S McMillen; K Waggie; R W Schreckhise; K Shoemaker; T Vu; M Moore; A Grossman; C H Clegg
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

7.  An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Authors:  B Schiemann; J L Gommerman; K Vora; T G Cachero; S Shulga-Morskaya; M Dobles; E Frew; M L Scott
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

8.  BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.

Authors:  L Banerji; J Glassford; N C Lea; N S Thomas; G G Klaus; E W Lam
Journal:  Oncogene       Date:  2001-11-01       Impact factor: 9.867

9.  BAFF mediates survival of peripheral immature B lymphocytes.

Authors:  M Batten; J Groom; T G Cachero; F Qian; P Schneider; J Tschopp; J L Browning; F Mackay
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

10.  Nuclear factor kappa B is required for the development of marginal zone B lymphocytes.

Authors:  A Cariappa; H C Liou; B H Horwitz; S Pillai
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

View more
  26 in total

1.  Regulation of B cell activating factor (BAFF) receptor expression by NF-ΚB signaling in rheumatoid arthritis B cells.

Authors:  Yun Ju Woo; Bo Young Yoon; Joo Yeon Jhun; Hye Jwa Oh; Se Won Min; Mi La Cho; Sung Hwan Park; Ho Youn Kim; Jun Ki Min
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

Review 2.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

3.  Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.

Authors:  Sarah F Andrews; Xuezhi Dai; Byoung Y Ryu; Tod Gulick; Bindu Ramachandran; David J Rawlings
Journal:  Eur J Immunol       Date:  2012-05       Impact factor: 5.532

Review 4.  Targeting BAFF in autoimmunity.

Authors:  Anne Davidson
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

Review 5.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 6.  NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

Authors:  Li Yu; Ling Li; L Jeffrey Medeiros; Ken H Young
Journal:  Blood Rev       Date:  2016-10-13       Impact factor: 8.250

7.  The development of mature B lymphocytes requires the combined function of CD19 and the p110δ subunit of PI3K.

Authors:  Dorottya Kövesdi; Sarah E Bell; Martin Turner
Journal:  Self Nonself       Date:  2010-03-11

Review 8.  NF-κB pathways in hematological malignancies.

Authors:  Chiara Gasparini; Claudio Celeghini; Lorenzo Monasta; Giorgio Zauli
Journal:  Cell Mol Life Sci       Date:  2014-01-14       Impact factor: 9.261

Review 9.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 10.  Signalling crosstalk in B cells: managing worth and need.

Authors:  Michael P Cancro
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.